Hexagon Capital Partners’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-401
Closed -$15.3K 552
2025
Q1
$15.3K Sell
401
-3
-0.7% -$127 ﹤0.01% 835
2024
Q4
$17.7K Buy
404
+68
+20% +$2.99K ﹤0.01% 825
2024
Q3
$14.5K Sell
336
-98
-23% -$4.37K ﹤0.01% 816
2024
Q2
$19.6K Sell
434
-208
-32% -$10.8K ﹤0.01% 692
2024
Q1
$40.1K Buy
642
+106
+20% +$6.34K 0.01% 477
2023
Q4
$30K Buy
536
+197
+58% +$9.82K 0.01% 526
2023
Q3
$17.9K Buy
+339
New +$19.8K ﹤0.01% 586

Other funds holding ENOV

Hexagon Capital Partners's ENOV Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Enovis (ENOV) in Q2 2025, closing a stake of 401 shares — an estimated $15.3K sold.

Hexagon Capital Partners first reported a position in ENOV in Q3 2023 and held it in 7 quarters. The position peaked at $40.1K in Q1 2024. 285 funds tracked by Wall St. Rank hold ENOV as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Enovis position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 401 Enovis shares in Q2 2025, an estimated $15.3K.
  • Hexagon Capital Partners first reported a position in Enovis in Q3 2023 and held it in 7 quarters.
  • Hexagon Capital Partners's Enovis position peaked at $40.1K in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Enovis as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.